Hepatocellular carcinoma is the most common primary liver cancer and it represents the
majority of cancer-related deaths in the world. More than 70% of patients present at an …

PURPOSE: This article reviews the role of selective internal irradiation (SIR) with yttrium-90
(90Y) microspheres for hepatocellular carcinoma (HCC). METHODS AND MATERIALS …

Background Selective internal radiation therapy (SIRT) with yttrium-90 resin (Y-90 resin)
microspheres has been used as a locoregional therapy for patients with unresectable …

Background This retrospective analysis was undertaken to evaluate the efficiency of SIRT
with Y-90 microspheres and determined prognostic factors affecting patients with …

Hepatocellular carcinoma (HCC) constitutes a difficult health challenge because of its poor
prognosis and limited treatment options. Most available therapies are used only for …

Background Hepatocellular carcinoma (HCC) is subject to different management
approaches and guidelines according to Eastern and Western therapeutic algorithms. Use …

Radioembolization has been demonstrated to allow locoregional therapy of patients with
hepatocellular carcinoma not eligible for transarterial chemoembolization or other local …

Yttrium-90 microspheres are radioactive particles which are increasingly being employed for
treating patients with unresectable hepatocellular carcinoma (HCC). The procedure is called …

To present a critical review of yttrium-90 (TheraSphere) for the treatment of hepatocellular
carcinoma (HCC). Medical literature databases (Medline, Cochrane Library, and …

A small percentage of patients with hepatocellular carcinoma (HCC) are candidates for
curative treatment in form of resection or transplantation. There are different treatment …